End-to-End PMO Partnerships Recent integration with Aji Bio-Pharma signals Gene Tools' capability and willingness to support customers from discovery through early clinical development. This creates a sales opportunity to pitch integrated PMO synthesis, purification, and manufacturing services to mid-sized biotechs and CROs seeking seamless translational workflows.

Scale-Up Collaboration With a focus on Morpholino oligos and a clear path toward larger-scale production, Gene Tools can address scale-up and purification needs for customers transitioning from bench-scale research to GMP-grade manufacturing. Target CMOs and biopharma clients needing end-to-end PMO capabilities, and offer bundled services, rapid scale-up options, and regulatory support.

Niche Differentiation As a smaller specialized supplier, Gene Tools can win business on customization, responsiveness, and early-stage PMO expertise. Position as a flexible partner for academic-industry collaborations and niche RNA-targeting projects where large vendors underperform on agility and bespoke synthesis.

Digital Marketing Advantage Leverage the existing tech stack to optimize lead generation and customer onboarding. Propose implementing a CRM, lead scoring, and content marketing around Morpholino applications to attract biotech startups and academic labs, shorten sales cycles, and improve after-sales support.

Strategic Account Growth The lean team coupled with revenue potential suggests pursuing multi-year contracts with high-value customers. Target RNA research and gene therapy programs, offering ongoing PMO supply, custom modifications, and long-term collaboration with Aji and other CMOs to secure recurring revenue.